Quick10K

⚲

Gala Pharmaceutical

Filings

10-Q	2019-05-31	Filed 2019-07-23
10-Q	2019-02-28	Filed 2019-04-30
10-K	2018-11-30	Filed 2019-04-15
10-Q	2018-08-31	Filed 2018-10-26
10-Q	2018-05-31	Filed 2018-08-01
10-Q	2018-02-28	Filed 2018-05-08
10-K	2017-11-30	Filed 2018-04-06
10-Q	2017-08-31	Filed 2017-10-19
10-Q	2017-05-31	Filed 2017-07-28
10-Q	2017-02-28	Filed 2017-04-18
10-K	2016-11-30	Filed 2017-03-09
10-Q	2016-08-31	Filed 2016-11-04
10-Q	2016-05-31	Filed 2016-07-15
10-Q	2016-02-29	Filed 2016-05-10
10-K	2015-11-30	Filed 2016-03-22
10-Q	2015-08-31	Filed 2015-10-20
10-Q	2015-05-31	Filed 2015-07-30
10-Q	2015-02-28	Filed 2015-04-22
10-K	2014-11-30	Filed 2015-03-13
10-Q	2014-08-31	Filed 2014-10-20
10-Q	2014-05-31	Filed 2014-07-18
10-Q	2014-02-28	Filed 2014-04-28
10-K	2013-11-30	Filed 2014-04-18
10-Q	2013-08-31	Filed 2013-10-29
10-Q	2013-02-28	Filed 2013-04-15
10-K	2012-11-30	Filed 2013-03-14
10-Q	2012-08-31	Filed 2012-10-15
10-Q	2012-05-31	Filed 2012-07-18
10-Q	2012-02-29	Filed 2012-04-23
10-K	2011-11-30	Filed 2012-03-13
10-Q	2011-08-31	Filed 2011-11-09

Reports

8-K	2020-04-29
8-K	2019-10-16
8-K	2019-03-19
8-K	2019-01-10
8-K	2019-01-02
8-K	2018-11-30
8-K	2018-09-26
8-K	2018-07-09
8-K	2018-06-20
8-K	2018-01-10

Gala Pharmaceutical Financials

GLAG Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
CNB Financial (CCNE)	450,404		5.1	1%	3,541,170	3,244,137	0	0	38,542	77,627	398,243
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
Timberline Resources (TLR)
Almost Never Films (HLWD)
1st United Bancorp (FUBC)
Manchester United (MANU)				0%	1,496,525		0	0	0	0	-307,637
SQL Technologies (SQFL)		18%	1.5	0%	6,991	29,884	9,299	1,628	0	1,813	2,696
2-Track Global (TTG)
GB Sciences (GBLX)	22,981	-23%	-1.8	-56%	29,840	15,525	3,909	-891	-16,597	-12,951	23,417
Nemaura Medical (NMRD)	158,102		-32.0	-182%	2,704	2,507	0	0	-4,919	-4,879	156,331
Monroe Bank and Trust (MBTF)	231,777		-6.6	1%	1,326,547	1,191,110	0	0	10,048	16,197	-106,841
Solis Tek (SLTK)	43,678	51%	-25.8	-163%	1,378	6,785	1,895	973	-2,244	-1,693	43,612
Cumulus Media (CMLS)			-94.7	-0%			0	0	0	-10,600	1,003,622
Cyclo Therapeutics, Inc. (CYTHW)
ALABAMA POWER CO (APRCP)


Balance Sheet ($'000)	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-08-31	2018-11-30	2019-02-28	2019-05-31
Cash	3	0		0	25	12	6	0	0	0	0	0	0	0	0	0	2	14	2	2	11	0	252	61	8	0	39	15	116	179	37
Accounts Receivable
Inventory																	3	2	2	7	2	2	2	2	2	2	2	2	0	0
PP&E			1	1	0	0	0	0	0															100	53	53	53	51	51	58	322
Assets	4	1	1	1	25	12	6	1	0	0	0	53	0	16	194	115	7	30	14	9	13	2	359	361	108	321	266	248	262	283	386
Accounts Payable					5	1	4
Long-Term Debt																													244	241	276
Liabilities	0	0	1	20	26	23	26	26	37	46	27	117	193	241	303	389	471	354	388	433	461	482	499	752	1,014	956	967	1,455	1,121	1,633	3,464
Stockholders' Equity	4	1	0	-19	-1	-11	-20	-25	-37	-46	-27	-64	-193	-225	-109	-274	-464	-323	-374	-424	-448	-479	-140	-391	-906	-635	-697	-1,198	-811	-1,281	-2,991


Income Statement ($'000)	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-08-31	2018-11-30	2019-02-28	2019-05-31
Revenue		0	0	0		0	0	0	0	0	0	0	0	0	0	0											5	0		0	0
Cost of Revenue				0		0	0																				3	0		0	0
Gross Profit				0		0	0																				1	0		0	0
R&D
SG&A		3	1	19	29	10	8	6	1	5	2	21	26	22	36	19	3	12	18	9	12	11	15	29	36	36	109	20		39	77
Tax		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0		0	0
Net Income		-3	-1	-19	-29	-10	-8	-6	-12	-8	-5	-37	-228	-260	-96	-208	-116	-45	-51	-50	-24	-31	-373	-695	-882	-583	-394	-712		-577	-2,113


Cash Flow ($'000)	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-08-31	2018-11-30	2019-02-28	2019-05-31
Cash Operating		-3	-0	0	-22	-13	-6	-5	-0	-3	7	-29	-36	-39	-24	-51	-13	-2	-37	-22	-10	-23	-17	-186	-98	-83	-161	-100		-108	-99
Cash Investing		0	0	0	0	0	0	0	0	0	0	-53	-137	-12	5	0	7	0	0	0	0			-115	-5			0		-7	-264
Cash Financing		0	0	0	47	0	0	0	0	31	-7	82	173	51	19	51	8	14	25	22	19	12	274	110	50	75	200	75		178	221